Follows Recent Launch of DeepIntent’s Innovative Patient Planner to Simplify Audience Creation and Campaign Activation NEW YORK, October 17, 2022 – DeepIntent, the leading …
Company to be featured Oct. 3 in the New York’s Most Respected Employers Issue NEW YORK, September 30, 2022 – DeepIntent, the leading healthcare …
NEW YORK, September 23, 2022 – PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named …
Latest Innovation Solves Pharma Brands’ and Agencies’ Long-standing Need for Transparent, Data-driven DTC Audience Creation and Campaign Planning NEW YORK, September 7, 2022 – …
Seasoned Executive Brings Expertise with High-Growth Companies as Pharma Programmatic Advertising Spending Dramatically Increases NEW YORK, August 8, 2022 – DeepIntent, the leading healthcare …
Over two dozen pharma brands and agencies have embraced the industry’s first and only healthcare-specific data marketplace with hundreds of ready-to-activate custom segments NEW …
Matterkind uses DeepIntent Outcomes’ patented technology to improve audience quality and script performance NEW YORK, June 15, 2022 – DeepIntent, the leading healthcare advertising …
Partnership brings Clinch’s industry-leading platform, Flight Control, with advanced ad serving, DCO and consumer intelligence capabilities to healthcare brands looking to optimize outcomes and …
Research affirms consumers find CTV ads more relevant as DeepIntent enhances unique audience targeting and campaign optimization capabilities with viewership data from 30+ million …
